Your browser doesn't support javascript.
loading
Lomitapide repurposing for treatment of malignancies: A promising direction.
Wu, Hua-Tao; Wu, Bing-Xuan; Fang, Ze-Xuan; Wu, Zheng; Hou, Yan-Yu; Deng, Yu; Cui, Yu-Kun; Liu, Jing.
Afiliação
  • Wu HT; Department of General Surgery, the First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Wu BX; The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Fang ZX; Department of General Surgery, the First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Wu Z; The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Hou YY; The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Deng Y; Department of Physiology/Changjiang Scholar's Laboratory, Shantou University Medical College, Shantou, 515041, China.
  • Cui YK; The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Liu J; Department of Physiology/Changjiang Scholar's Laboratory, Shantou University Medical College, Shantou, 515041, China.
Heliyon ; 10(12): e32998, 2024 Jun 30.
Article em En | MEDLINE | ID: mdl-38988566
ABSTRACT
The development of novel drugs from basic science to clinical practice requires several years, much effort, and cost. Drug repurposing can promote the utilization of clinical drugs in cancer therapy. Recent studies have shown the potential effects of lomitapide on treating malignancies, which is currently used for the treatment of familial hypercholesterolemia. We systematically review possible functions and mechanisms of lomitapide as an anti-tumor compound, regarding the aspects of apoptosis, autophagy, and metabolism of tumor cells, to support repurposing lomitapide for the clinical treatment of tumors.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China